Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
332 | 17329 | 37.9 | 71% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
158 | 57580 | COMPLEMENT//JOURNAL OF IMMUNOLOGY//COMMON VARIABLE IMMUNODEFICIENCY |
Classes in level below (level 1) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | COMPLEMENT | Author keyword | 970 | 40% | 11% | 1907 |
2 | MANNOSE BINDING LECTIN | Author keyword | 468 | 72% | 2% | 365 |
3 | PAROXYSMAL NOCTURNAL HEMOGLOBINURIA | Author keyword | 335 | 77% | 1% | 229 |
4 | MANNAN BINDING LECTIN | Author keyword | 212 | 82% | 1% | 122 |
5 | ECULIZUMAB | Author keyword | 192 | 71% | 1% | 154 |
6 | LECTIN PATHWAY | Author keyword | 182 | 83% | 1% | 104 |
7 | CD59 | Author keyword | 164 | 60% | 1% | 180 |
8 | FACTOR H | Author keyword | 158 | 63% | 1% | 158 |
9 | C3 | Author keyword | 142 | 50% | 1% | 207 |
10 | FICOLIN | Author keyword | 140 | 86% | 0% | 72 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | COMPLEMENT | 970 | 40% | 11% | 1907 | Search COMPLEMENT | Search COMPLEMENT |
2 | MANNOSE BINDING LECTIN | 468 | 72% | 2% | 365 | Search MANNOSE+BINDING+LECTIN | Search MANNOSE+BINDING+LECTIN |
3 | PAROXYSMAL NOCTURNAL HEMOGLOBINURIA | 335 | 77% | 1% | 229 | Search PAROXYSMAL+NOCTURNAL+HEMOGLOBINURIA | Search PAROXYSMAL+NOCTURNAL+HEMOGLOBINURIA |
4 | MANNAN BINDING LECTIN | 212 | 82% | 1% | 122 | Search MANNAN+BINDING+LECTIN | Search MANNAN+BINDING+LECTIN |
5 | ECULIZUMAB | 192 | 71% | 1% | 154 | Search ECULIZUMAB | Search ECULIZUMAB |
6 | LECTIN PATHWAY | 182 | 83% | 1% | 104 | Search LECTIN+PATHWAY | Search LECTIN+PATHWAY |
7 | CD59 | 164 | 60% | 1% | 180 | Search CD59 | Search CD59 |
8 | FACTOR H | 158 | 63% | 1% | 158 | Search FACTOR+H | Search FACTOR+H |
9 | C3 | 142 | 50% | 1% | 207 | Search C3 | Search C3 |
10 | FICOLIN | 140 | 86% | 0% | 72 | Search FICOLIN | Search FICOLIN |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | 3RD COMPONENT | 429 | 69% | 2% | 366 |
2 | ALTERNATIVE PATHWAY | 377 | 49% | 3% | 553 |
3 | DECAY ACCELERATING FACTOR | 362 | 39% | 4% | 721 |
4 | HAKATA ANTIGEN | 321 | 95% | 1% | 104 |
5 | MEMBRANE COFACTOR PROTEIN | 296 | 59% | 2% | 335 |
6 | H FICOLIN | 287 | 97% | 0% | 85 |
7 | MEMBRANE ATTACK COMPLEX | 283 | 47% | 3% | 439 |
8 | ANAPHYLATOXIN | 248 | 72% | 1% | 197 |
9 | MBL | 237 | 79% | 1% | 150 |
10 | FACTOR DAF | 208 | 73% | 1% | 158 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | COMPLEMENT AND INFLAMMATION | 97 | 78% | 0% | 64 |
2 | MOLECULAR IMMUNOLOGY | 76 | 10% | 4% | 692 |
3 | EXPERIMENTAL AND CLINICAL IMMUNOGENETICS | 10 | 15% | 0% | 66 |
4 | PROGRESS IN ALLERGY | 3 | 14% | 0% | 23 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Complement: a key system for immune surveillance and homeostasis | 2010 | 655 | 165 | 67% |
Advances in immunology: Complement (First of two parts). | 2001 | 1395 | 54 | 67% |
MEDICAL PROGRESS Atypical Hemolytic-Uremic Syndrome | 2009 | 286 | 86 | 84% |
Complement regulators and inhibitory proteins | 2009 | 283 | 103 | 71% |
Is the Complement Activation Product C3a a Proinflammatory Molecule? Re-evaluating the Evidence and the Myth | 2015 | 3 | 61 | 90% |
Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies | 2012 | 92 | 74 | 82% |
Atypical hemolytic uremic syndrome | 2011 | 111 | 141 | 83% |
Complement and its role in innate and adaptive immune responses | 2010 | 177 | 149 | 79% |
Mannose-binding lectin: The pluripotent molecule of the innate immune system | 1996 | 537 | 63 | 86% |
The role of mannose-binding lectin in health and disease | 2003 | 330 | 49 | 96% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | COMPLEMENT BIOL GRP | 50 | 71% | 0.2% | 41 |
2 | ENZYMOL MOL | 42 | 62% | 0.2% | 43 |
3 | NO MOL GENET SERV | 38 | 93% | 0.1% | 14 |
4 | STELLAR CHANCE S 401 | 38 | 93% | 0.1% | 14 |
5 | IMMUNOBIOL INFECT | 32 | 80% | 0.1% | 20 |
6 | TISSUE TYPING 7631 | 31 | 76% | 0.1% | 22 |
7 | SERV IMMUNOL BIOL | 31 | 34% | 0.4% | 74 |
8 | IMMUNOCHEM UNIT | 29 | 27% | 0.5% | 93 |
9 | COMPLEMENT INFLAMMAT | 26 | 53% | 0.2% | 35 |
10 | BRAIN INFLAMMAT IMMUN GRP | 19 | 70% | 0.1% | 16 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000011642 | EXPERIMENTAL LEPROSY//IGA ALPHA 1 ANTITRYPSIN COMPLEX//IGA ALPHA1 ANTITRYPSIN COMPLEX |
2 | 0.0000009457 | XENOTRANSPLANTATION//PORCINE ENDOGENOUS RETROVIRUSES//PERV |
3 | 0.0000008254 | FCRN//NEONATAL FC RECEPTOR//FC GAMMA RECEPTORS |
4 | 0.0000007648 | THROMBOTIC THROMBOCYTOPENIC PURPURA//ADAMTS 13//HEMOLYTIC UREMIC SYNDROME |
5 | 0.0000006498 | CLUSTERIN//ELASTOFIBROMA//ELASTOFIBROMA DORSI |
6 | 0.0000006215 | HEREDITARY ANGIOEDEMA//C1 INHIBITOR//ANGIOEDEMA |
7 | 0.0000004527 | HAPTOGLOBIN//PENTRAXIN 3//PTX3 |
8 | 0.0000004508 | NEISSERIA MENINGITIDIS//MENINGOCOCCAL DISEASE//MENINGOCOCCAL REFERENCE UNIT |
9 | 0.0000004298 | HLA B8 DR3//INTERDISCIPLINARY STUDIES SECT//AH 81 |
10 | 0.0000004265 | IGA NEPHROPATHY//PODOCYTE//NEPHRIN |